Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

NCT: NCT06777368 · RECRUITING

NCT IDNCT06777368
StatusRECRUITING
Start Date2025-02-06
Completion2027-11

Brief Summary

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).

Frequently Asked Questions

What is REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE?

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE is a clinical trial registered under NCT06777368. Current status: RECRUITING.

What is the status of NCT06777368?

The current status of NCT06777368 (REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE) is: RECRUITING.

When did REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE start?

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE started on 2025-02-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑